company-logo

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.

Bioventus Dividend Announcement

Bioventus does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Bioventus dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Bioventus Dividend History

Bioventus Dividend Yield

Bioventus current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Bioventus stock? Use our calculator to estimate your expected dividend yield:

Bioventus Financial Ratios

P/E ratio-20.56
PEG ratio2.40
P/B ratio5.46
ROE-24.50%
Payout ratio0.00%
Current ratio1.41
Quick ratio0.99
Cash Ratio0.20

Bioventus Dividend FAQ

Does Bioventus stock pay dividends?
Bioventus does not currently pay dividends to its shareholders.
Has Bioventus ever paid a dividend?
No, Bioventus has no a history of paying dividends to its shareholders. Bioventus is not known for its dividend payments.
Why doesn't Bioventus pay dividends?
There are several potential reasons why Bioventus would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Bioventus ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Bioventus has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Bioventus a dividend aristocrat?
Bioventus is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Bioventus a dividend king?
Bioventus is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Bioventus a dividend stock?
No, Bioventus is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Bioventus stocks?
To buy Bioventus you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Bioventus stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.